Although the data presented here demonstrated that NR2F1‐AS1 expression is positively related to dormancy in luminal type breast cancer, one limitation of this study is that we could not identify the key molecules or signals of how the dormant cells wake and expand in the secondary tumors at distal organs. Here, NR2F1 is linked to breast cancer.